| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |